Team marks milestone in progress toward investigational new drug for triple-negative breast cancer

A new compound shows promise in overcoming chemotherapy resistance in triple-negative breast cancer -- and could potentially be applied to fibrotic conditions like liver fibrosis or pulmonary fibrosis.